Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple breathing exercises cut frailty in elderly COPD patients

NCT ID NCT07472530

First seen Mar 17, 2026 · Last updated Jun 19, 2026 · Updated 18 times

Summary

This study tested whether a six-week program of breathing exercises using a device called an incentive spirometer could help older adults (65+) with COPD who were also frail. 66 participants were split into two groups: one did the breathing exercises, the other did not. After six weeks, those who did the exercises showed better lung function, could walk farther, felt less short of breath, and had lower frailty scores. The results suggest that adding simple breathing exercises to COPD care might improve both physical strength and quality of life in older patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Çerkeş State Hospital

    Çankırı, Merkez, 18100, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

breathing exercises using an incentive spirometer (Triflow device)

What this could lead to

If confirmed, this simple breathing exercise program could become a standard part of COPD care for older adults, helping them feel stronger and breathe easier.

What could go wrong

This was a small, single-blind trial with 66 participants, so results may not apply to everyone. The improvements were modest and need to be replicated in larger, longer studies.

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset Dyspnea Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.